Surrogates for fracture endpoints in clinical trials.
Khosla
Sundeep
S
Endocrine Research Unit, Division of Endocrinology, Metabolism, and Nutrition, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA. khosla.sundeep@mayo.edu
D015519:Bone Density; D002986:Clinical Trials as Topic / Q000592:standards*; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D050723:Fractures, Bone / Q000453:epidemiology / Q000208:ethnology* / Q000517:prevention & control; D006801:Humans; D015201:Meta-Analysis as Topic; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000208:ethnology; D010919:Placebos / Q000592:standards; D017698:Postmenopause; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D012306:Risk; D012307:Risk Factors
D004967:Estrogens; D010919:Placebos